Ashley Richards
Psychiatric/Mental Health · Greenville, SCNPI 1881107167
Payments from drug & device makers
Across 125 payments — averaging $14.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Takeda Pharmaceuticals U.S.A., Inc.$365
- Axsome Therapeutics, Inc.$287
- AbbVie$273
- Sunovion Pharmaceuticals Inc.$234
- Lundbeck LLC$101
- Vanda Pharmaceuticals Inc.$89
- plus $429 from 10 others
What the payments were for
- Food & beverage$1,73197%
- Education$473%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 37 | $365 |
| Axsome Therapeutics, Inc. | 15 | $287 |
| AbbVie | 25 | $273 |
| Sunovion Pharmaceuticals Inc. | 14 | $234 |
| Lundbeck LLC | 7 | $101 |
| Vanda Pharmaceuticals Inc. | 3 | $89 |
| Bausch Health US, LLC | 5 | $87 |
| Adlon Therapeutics L.p. | 4 | $76 |
| Otsuka America Pharmaceutical, Inc. | 5 | $72 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $47 |
| Johnson & Johnson | 2 | $35 |
| Eisai Inc. | 2 | $30 |
| Merck | 2 | $28 |
| Orexo US, Inc. | 1 | $19 |
| Avanir Pharmaceuticals, Inc. | 1 | $18 |
| Teva Pharmaceuticals USA, Inc. | 1 | $17 |
How this compares
$1,778 in reported general payments places this provider in the 70th percentile of 354 psychiatric/mental health providers in South Carolina.
See all psychiatric/mental health providers in South Carolina →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RexultiBrexpiprazole | 20 | $34,150 |
| Bupropion XlBupropion Hcl | 79 | $1,599 |
| Trazodone Hcl | 126 | $1,130 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 45 | $1,093 |
| Alprazolam | 164 | $1,069 |
| Quetiapine Fumarate | 83 | $919 |
| Fluoxetine Hcl | 85 | $867 |
| Duloxetine Hcl | 59 | $828 |
| Lamotrigine | 96 | $730 |
| Prazosin Hcl | 42 | $729 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 16 | $698 |
| Aripiprazole | 35 | $636 |
| Olanzapine | 39 | $604 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 32 | $530 |
| Clonazepam | 123 | $462 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Otsuka America Pharmaceutical, Inc.Rexulti | $72 | $34,15020 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 354 psychiatric/mental health providers in South Carolina.
Other psychiatric/mental health in Greenville
- Steven KrozerGreenville$139K
- Luron FlemingGreenville$61K
- Lauren DyerGreenville$16K
- Melissa BrownGreenville$16K
- William HendricksGreenville$13K
- Carrie BallengerGreenville$11K
- Gregory SmithGreenville$9K
- Svetlana RobinsonGreenville$8K
- Jared CarboneGreenville$7K
- Anglique RichGreenville$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.